# Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns

> **NCT05097924** · — · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 150 (actual)

## Conditions studied

- Infant Nutritional Physiological Phenomena
- Infant Formula

## Interventions

- **OTHER:** NAN Supreme HypoAllergenic Starter Infant Formula in ready-to-feed format

## Key facts

- **NCT ID:** NCT05097924
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2022-03-09
- **Final completion:** 2022-03-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05097924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05097924, "Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05097924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
